incivo
janssen-cilag international n.v. - telaprevir - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - incivo, u kombinaciji sa peg interferonom alfa i ribavirinom, indiciran za liječenje genotip 1 kroničnog hepatitisa c kod odraslih pacijenata s компенсированным bolesti jetre (uključujući cirozu):koji je tretman naivan, koji je ranije liječenje interferonom alfa (пегилированным ili пегилированным) kao monoterapija ili u kombinaciji sa ribavirinom, uključujući i recidiv, djelomični okrivljenika i неответчики.
ciprinol 200 mg/100 ml otopina za infuziju
krka farma d.o.o. sarajevo - ciprofloksacin - otopina za infuziju - 200 mg/100 ml - 1 ml otopine za infuziju sadrži: 2mg ciprofloksacina (u obliku ciprofloksacin laktata)
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
entresto
novartis europharm limited - sacubitril, валсартан - zastoj srca - antagonisti angiotenzina ii, druge kombinacije, agenti koji djeluju na ренин-ангиотензиновую sustav - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
neparvis
novartis europharm limited - sacubitril, валсартан - zastoj srca - sredstva koja djeluju na sustav renin-angiotenzina - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
ciflox 2 mg/ml otopina za infuziju
belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica - ciprofloxacinum - otopina za infuziju - 2 mg/ml - urbroj: 1 ml otopine za infuziju sadrži 2 mg ciprofloksacina u obliku ciprofloksacinlaktata
cifloxinal 500 mg/1 tableta film tableta
pro.med. bh d.o.o. - ciprofloksacin - film tableta - 500 mg/1 tableta - 1 film tableta sadrži: 500 mg ciprofloksacin (u obliku ciprofloksacinhidrohlorida)
ciprol 500 mg/1 tableta film tableta
bosnalijek d.d. - ciprofloksacin - film tableta - 500 mg/1 tableta - 1 film tableta sadrži: 500 mg ciprofloksacina (u obliku ciprofloksacinhidrohlorida)
ciprozad 250 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - ciprofloksacin - film tableta - 250 mg/1 tableta - 1 filmtableta sadrži: 250 mg ciprofloksacin (u obliku ciprofloksacinhidrohlorid, monohidrata)
ciprozad 500 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - ciprofloksacin - film tableta - 500 mg/1 tableta - 1 filmtableta sadrži: 500 mg ciprofloksacin (u obliku ciprofloksacinhidrohlorid, monohidrata)